[
  {
    "question": "The gold standard for definitive diagnosis of pulmonary hypertension is?",
    "options": {
      "A": "Echocardiography",
      "B": "CT Pulmonary Angiography",
      "C": "Right Heart Catheterization",
      "D": "Cardiopulmonary Exercise Test"
    },
    "correctAnswer": "C",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "Right Heart Catheterization (RHC) is the gold standard for diagnosing pulmonary hypertension (PH) as it directly measures pulmonary artery pressures, pulmonary capillary wedge pressure, and cardiac output, allowing for accurate calculation of pulmonary vascular resistance and classification of PH type (pre-capillary, post-capillary, or combined).",
    "highYieldPearl": "RHC provides direct hemodynamic measurements essential for PH diagnosis and classification.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "Echocardiography is an excellent screening tool but provides estimated pressures. CTPA is crucial for CTEPH and other lung pathologies but not for definitive hemodynamic diagnosis. CPET assesses functional capacity but not direct pressures.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_g4p3h8qw"
  },
  {
    "question": "According to current guidelines, the mean pulmonary artery pressure (mPAP) threshold for diagnosing pulmonary hypertension at rest is?",
    "options": {
      "A": ">25 mmHg",
      "B": ">20 mmHg",
      "C": ">30 mmHg",
      "D": ">18 mmHg"
    },
    "correctAnswer": "B",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "The updated 2022 ESC/ERS guidelines for pulmonary hypertension define PH as a mean pulmonary artery pressure (mPAP) >20 mmHg at rest, measured by right heart catheterization. Previously, the threshold was >25 mmHg.",
    "highYieldPearl": "The diagnostic mPAP threshold has been lowered to >20 mmHg in recent guidelines.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "The >25 mmHg threshold was used in older guidelines. Knowing this recent update is crucial for current exams.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_2ts532o0"
  },
  {
    "question": "Pre-capillary pulmonary hypertension is hemodynamically defined by mPAP >20 mmHg, PVR >2 Wood Units, and a pulmonary capillary wedge pressure (PCWP) of?",
    "options": {
      "A": ">15 mmHg",
      "B": "≤15 mmHg",
      "C": ">18 mmHg",
      "D": "≤12 mmHg"
    },
    "correctAnswer": "B",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "Pre-capillary PH is characterized by elevated mPAP (>20 mmHg) and pulmonary vascular resistance (PVR >2 Wood Units) in the presence of a normal or low pulmonary capillary wedge pressure (PCWP ≤15 mmHg), indicating the primary pathology is in the pulmonary arterioles.",
    "highYieldPearl": "Pre-capillary PH = high mPAP, high PVR, normal/low PCWP.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "A PCWP >15 mmHg with elevated mPAP would indicate post-capillary PH (Group 2), often due to left heart disease.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_m0w6shjz"
  },
  {
    "question": "The recommended initial non-invasive screening test for suspected pulmonary hypertension is?",
    "options": {
      "A": "Chest X-ray",
      "B": "Electrocardiogram (ECG)",
      "C": "Transthoracic Echocardiography",
      "D": "Pulmonary Function Tests (PFTs)"
    },
    "correctAnswer": "C",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "Transthoracic echocardiography is the primary screening tool for PH due to its ability to estimate pulmonary artery systolic pressure, assess right ventricular size and function, and evaluate for left heart disease, which can cause PH.",
    "highYieldPearl": "Echocardiography is the first-line non-invasive test for PH screening.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "Chest X-ray and ECG can show signs suggestive of PH (e.g., RV hypertrophy, prominent pulmonary arteries) but are non-specific. PFTs help identify underlying lung disease but don't directly screen for PH hemodynamics.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_6dpq3yhj"
  },
  {
    "question": "The recommended initial imaging test to rule out Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in a patient with suspected PH is?",
    "options": {
      "A": "CT Pulmonary Angiography (CTPA)",
      "B": "Ventilation/Perfusion (V/Q) Scan",
      "C": "MRI Pulmonary Angiography",
      "D": "Digital Subtraction Angiography (DSA)"
    },
    "correctAnswer": "B",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "A V/Q scan is highly sensitive for detecting chronic thromboembolic disease and is the recommended initial imaging modality for screening CTEPH. A normal V/Q scan effectively rules out CTEPH. If abnormal, CTPA or DSA are then used for detailed anatomical assessment.",
    "highYieldPearl": "V/Q scan is the most sensitive screening test for CTEPH.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "CTPA is excellent for acute PE and characterizing CTEPH once suspected, but its sensitivity for chronic thromboembolic disease is lower than V/Q scan. DSA is the gold standard for detailed vascular anatomy but is invasive and not a screening test.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_drq6zc9n"
  },
  {
    "question": "Vasoreactivity testing during right heart catheterization is primarily performed in which group of pulmonary hypertension?",
    "options": {
      "A": "Group 1: Pulmonary Arterial Hypertension (PAH)",
      "B": "Group 2: PH due to Left Heart Disease",
      "C": "Group 3: PH due to Lung Diseases and/or Hypoxia",
      "D": "Group 4: Chronic Thromboembolic PH (CTEPH)"
    },
    "correctAnswer": "A",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "Vasoreactivity testing is crucial in Group 1 PAH (especially idiopathic, heritable, or drug/toxin-induced PAH) to identify patients who may respond to calcium channel blockers. It is not recommended for other PH groups.",
    "highYieldPearl": "Vasoreactivity testing guides treatment in specific Group 1 PAH patients.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "Vasoreactivity testing has no role or is potentially harmful in other PH groups, as their underlying pathologies are not primarily vasoreactive.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_p4h3p1ah"
  },
  {
    "question": "Which biomarker is most commonly used for prognostic assessment and monitoring disease progression in pulmonary hypertension?",
    "options": {
      "A": "C-reactive protein (CRP)",
      "B": "D-dimer",
      "C": "N-terminal pro-B-type natriuretic peptide (NT-proBNP)",
      "D": "High-sensitivity Troponin I"
    },
    "correctAnswer": "C",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "NT-proBNP (or BNP) levels correlate with right ventricular dysfunction and hemodynamic severity in PH. Elevated levels indicate worse prognosis and are used for risk stratification and monitoring treatment response.",
    "highYieldPearl": "Elevated BNP/NT-proBNP signifies worse RV function and prognosis in PH.",
    "examStyle": "NEET-SS",
    "difficulty": "Easy",
    "trapAnalysis": "CRP is a general inflammatory marker. D-dimer is for venous thromboembolism. Troponin indicates myocardial injury, which can occur in severe RV strain but is less specific for chronic PH monitoring than natriuretic peptides.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_4vih53ld"
  },
  {
    "question": "Exercise right heart catheterization is primarily considered for diagnosing pulmonary hypertension in patients with?",
    "options": {
      "A": "Overt PH at rest",
      "B": "Borderline PH at rest with unexplained dyspnea",
      "C": "Severe tricuspid regurgitation",
      "D": "Known CTEPH"
    },
    "correctAnswer": "B",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "Exercise RHC may be considered in patients with unexplained dyspnea and borderline PH hemodynamics at rest (mPAP 18-20 mmHg) to unmask exercise-induced PH. It is not routinely recommended for established PH or specific conditions like CTEPH.",
    "highYieldPearl": "Exercise RHC helps diagnose exercise-induced PH in symptomatic patients with borderline rest hemodynamics.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "For overt PH, rest RHC is sufficient. Severe TR is a consequence, not an indication for exercise RHC. CTEPH diagnosis relies on V/Q scan and angiography.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_q1gjxz7g"
  },
  {
    "question": "Genetic testing for BMPR2 mutation is most relevant in the diagnostic workup of which PH group?",
    "options": {
      "A": "Group 1: Heritable Pulmonary Arterial Hypertension (PAH)",
      "B": "Group 2: PH due to Left Heart Disease",
      "C": "Group 3: PH due to Lung Diseases",
      "D": "Group 5: PH with unclear multifactorial mechanisms"
    },
    "correctAnswer": "A",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "Mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene are the most common genetic cause of heritable PAH (a subgroup of Group 1 PAH). Genetic testing is recommended for all PAH patients to identify familial cases and inform counseling.",
    "highYieldPearl": "BMPR2 mutation is a key genetic marker for heritable PAH.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "While other PH groups can have genetic predispositions, BMPR2 is specifically linked to PAH and has significant diagnostic and prognostic implications within this group.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_2vx7m99f"
  },
  {
    "question": "High-resolution computed tomography (HRCT) of the chest in a PH workup is primarily used to assess for?",
    "options": {
      "A": "Right ventricular hypertrophy",
      "B": "Pulmonary artery pressures",
      "C": "Interstitial lung disease or emphysema",
      "D": "Left atrial enlargement"
    },
    "correctAnswer": "C",
    "topic": "ph_diagnosis",
    "deepDiveExplanation": "HRCT of the chest is crucial for identifying underlying lung parenchymal diseases, such as interstitial lung disease, emphysema, or other chronic lung conditions, which can cause Group 3 PH. It also helps rule out other causes like mediastinal fibrosis.",
    "highYieldPearl": "HRCT identifies underlying lung disease causing Group 3 PH.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "While HRCT can show signs of RV hypertrophy or main pulmonary artery enlargement, it does not directly measure pressures (B). Left atrial enlargement is better assessed by echocardiography. Its primary role in PH workup is for parenchymal lung pathology.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|ph_diagnosis|Pulmonary Hypertension - Diagnosis|10_8yh2hexi"
  }
]